BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 969 filers reported holding BAXTER INTL INC in Q3 2017. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $47,000 | +2.2% | 570 | 0.0% | 0.06% | -8.2% |
| Q1 2019 | $46,000 | +21.1% | 570 | 0.0% | 0.06% | -16.4% |
| Q4 2018 | $38,000 | -13.6% | 570 | 0.0% | 0.07% | +65.9% |
| Q3 2018 | $44,000 | +4.8% | 570 | 0.0% | 0.04% | 0.0% |
| Q2 2018 | $42,000 | +13.5% | 570 | 0.0% | 0.04% | +4.8% |
| Q1 2018 | $37,000 | 0.0% | 570 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $37,000 | +2.8% | 570 | 0.0% | 0.04% | -2.3% |
| Q3 2017 | $36,000 | -99.9% | 570 | 0.0% | 0.04% | +7.5% |
| Q2 2017 | $34,599,000 | +16.8% | 570 | 0.0% | 0.04% | +8.1% |
| Q1 2017 | $29,634,000 | +16.3% | 570 | 0.0% | 0.04% | +37.0% |
| Q4 2016 | $25,474,000 | +91.1% | 570 | +103.6% | 0.03% | +58.8% |
| Q3 2016 | $13,328,000 | +5.3% | 280 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $12,662,000 | +10.1% | 280 | 0.0% | 0.02% | +6.2% |
| Q1 2016 | $11,502,000 | +7.7% | 280 | 0.0% | 0.02% | +23.1% |
| Q4 2015 | $10,682,000 | +16.1% | 280 | 0.0% | 0.01% | +8.3% |
| Q3 2015 | $9,198,000 | -53.0% | 280 | 0.0% | 0.01% | -45.5% |
| Q2 2015 | $19,580,000 | +2.1% | 280 | 0.0% | 0.02% | -4.3% |
| Q1 2015 | $19,180,000 | -6.5% | 280 | 0.0% | 0.02% | -14.8% |
| Q4 2014 | $20,521,000 | – | 280 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |